NEW YORK & CARLSBAD, Calif.–Biotech Showcase™ Digital is the investor conference that drives the future of biotech innovation, digital medicine, and international collaboration. In its 13th year, the conference will be a virtual experience for attendees in an engaging, live and on-demand format delivered through partneringONE® between January 11–15, 2021. For the first time ever, content and presentations will be released beginning November 30, 2020. Register today to begin scheduling meetings with potential investors and partners.
In just the past five years, 250 companies that presented at Biotech Showcase have generated deals worth more than $61 Billion. The organizers anticipate more than 300 public and private presenting companies this year. A full list of currently registered presenting companies can be found here. More generally, noteworthy conference participants and sponsors include Ajinomoto, Alliance for Regenerative Medicine, Bayer, Global Genes, Novo Nordisk, Silicon Valley Bank and Startup Health.
“One of the industry’s largest annual healthcare investor and partnering conferences, Biotech Showcase brings together biopharma and life sciences thought leaders who set the tone and pace for the coming year in biotech,” said Tomas Landh, Innovation Sourcing Vice President, Senior Principal Scientist Search and Evaluation at Novo Nordisk. “Every year, our team looks forward to participating in meetings with our existing and potential partners during Biotech Showcase. 2021 will be no different other than the fact that the experience will be delivered in an innovative digital platform.”
To make the experience as valuable and seamless as possible, Biotech Showcase offers:
According to Sara Jane Demy, Founder and CEO, Demy-Colton, “As we continue navigating these unprecedented times and prepare for the promise of a new year, staying connected within the life sciences industry is more important than ever. In its virtual form, Biotech Showcase will continue to be a place to create a link between investors and the industry’s most promising biotech and pharmaceutical companies.”
Tina Gunnink, Managing Director, EBD Group US, added “Biotech Showcase remains one of the largest investor conferences for the life sciences’ most innovative companies and is a particularly pivotal touchpoint for those looking for partnerships and investment. We are looking forward to seeing the continued collaboration for Biotech Showcase 2021.”
Organizers anticipate more than 2,500 virtual attendees this year and have designed a program to provide them with industry updates and insights from leading executives and advisors as well as key sessions. Conference registration also gives attendees access to the Biotech Showcase™ program as well as its sister events Digital Medicine & Medtech Showcase and Seed Showcase.
For more information or to register for the event, visit www.biotechshowcase.com.
Since 2008, Demy-Colton has been at the forefront of building networks between leaders from innovative biotech companies and industry stakeholders to examine and address biotech opportunities and challenges and deliver on the promise of transformational science.
Demy-Colton achieves this with unique meeting platforms that facilitate networking and biotech community development on an international scale. Aside from Biotech Showcase™, its investor and specialized events include BioFuture™, CEO Summit Europe™, and CEO Summit Napa™, Demy-Colton Virtual Salons, and CEO Virtual Dialogues. Its events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry’s top decision makers, investors, and thought leaders.
Demy-Colton sets a unique stage where investment, learning, and growth thrive. Its events spur introductions and thoughtful conversations. In turn, inspiration, ideas, and opportunities for investment flow.
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life sciences value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life sciences markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, and BioEquity Europe) annually attract more than 15,000 senior life sciences executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.